Shelby StillwagonSenior Director, Decentralized Clinical Trials at ProPharma Group, USA
Shelby Stillwagon is Senior Director of Decentralized Clinical Trials at ProPharma Group. She started her career in academic research then moved to the clinical site environment working in oncology and has spent the past 8 years focused on supporting and operationalizing Decentralized Clinical Trials. Since 2013, Shelby has worked with numerous sponsors across hundreds of clinical trials where she’s provided expert guidance on decentralized visit design and logistics. She has held multiple oversight roles, supporting global teams across a wide variety of therapeutic areas including rare disease, pediatrics, oncology, neurology, and infectious disease. Her expertise is in collaborating with involved stakeholders (Sponsor, CRO, vendors, etc.) to build and maintain study-specific, quality-focused processes that support complex decentralized clinical trials.